Latest filing published 14 Jan 2020 for Idera Pharmaceuticals, INC..
No signal scores available.
Filings by Robert C. Fletcher span 2 companies, the busiest being Viropharma Inc and Idera Pharmaceuticals, Inc. In total, 37 filings cover trades dated from 29 December 2011 to 10 January 2020.
Sales make up the whole of the open-market record (3 sales, €720k). Besides market trades, the filings include 16 share grants and 16 option exercises. In 2020 alone, the filings show no purchases and 2 sales.
On 14 January 2020 came the latest disclosure, an open-market sale for €2,567 in Idera Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations